Literature DB >> 7865643

Bran supplementation in the treatment of irritable bowel syndrome.

J Snook1, H A Shepherd.   

Abstract

BACKGROUND: Irritable bowel syndrome remains the commonest reason for referral to a gastroenterology clinic. Patients with irritable bowel syndrome are frequently advised to increase their intake of bran fibre, despite inconclusive experimental evidence of benefit.
METHODS: The effect of dietary supplementation with a bolus of bran fibre (12 g/day) was studied in a block-randomized, placebo-controlled, crossover study of 80 patients with irritable bowel syndrome referred to a District General Hospital outpatient clinic. Comparison of the benefits of bran and placebo was based upon personal assessment of individual and overall symptom profiles, determined from a simple daily symptom score and post-treatment interview.
RESULTS: Overall symptomatic improvement was reported with bran by 52% and with placebo by 54% of patients. Bran supplementation was no more effective than placebo in improving individual symptoms of irritable bowel syndrome, and for wind-related symptoms it was significantly less effective (P < 0.001).
CONCLUSION: Dietary supplementation with bran is of no value in the treatment of patients with irritable bowel syndrome referred to a hospital clinic.

Entities:  

Mesh:

Year:  1994        PMID: 7865643     DOI: 10.1111/j.1365-2036.1994.tb00323.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  20 in total

1.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

Review 2.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

3.  Small bowel transit of a bran meal residue in humans: sieving of solids from liquids and response to feeding.

Authors:  J M Hebden; P E Blackshaw; A C Perkins; M D'Amato; R C Spiller
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

Review 4.  Treatment of irritable bowel syndrome: a review of randomised controlled trials.

Authors:  R Akehurst; E Kaltenthaler
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

5.  Current and emerging therapies for the management of functional gastrointestinal disorders.

Authors:  Orla F Craig; Eamonn M M Quigley
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

6.  Treatment of Irritable Bowel Syndrome.

Authors:  Robin C. Spiller
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08

7.  Food Intolerance: Dietary Treatments in Functional Bowel Disorders.

Authors:  Maria O'Sullivan; Colm O'Morain
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08

8.  Inhibitory actions of a high fibre diet on intestinal gas transit in healthy volunteers.

Authors:  S Gonlachanvit; R Coleski; C Owyang; Wl Hasler
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

9.  Effects of anti-secretory factor (ASF) on irritable bowel syndrome (IBS). A double-blind, randomized study.

Authors:  Rickard Ekesbo; Peter M Nilsson; Kristina Sjölund
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

Review 10.  Complementary and alternative medicine for treatment of irritable bowel syndrome.

Authors:  Yi-Hao A Shen; Richard Nahas
Journal:  Can Fam Physician       Date:  2009-02       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.